Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of Nepafenac 1 mg/ml Eye Drops, Suspension, compared to
Placebo and Ketorolac Trometamol 5 mg/ml Eye Drops, Solution for the prevention and treatment
of ocular inflammation and ocular pain after cataract extraction with IOL implantation